Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

67053 1513184208HCLSReviewBulgariaDecember2017.pdf
Energy Boardroom

The Luxury of Uncertainty

23.06.2014 / Thomson Reuters Blog

Biosimilar competition continues to trend as a significant topic in the pharmaceutical industry for many reasons. First, the biologic products targeted for competition over the next five years rank among some of the highest grossing franchises globally, including Humira, Enbrel, Rituxan, Remicade and Herceptin. With each target driving between $1B-$5B in US dose sales alone, […]

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: